Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment.

ABSTRACT:

Background

Limited data are available regarding second-line (2 L) treatment for advanced or metastatic biliary tract cancers (BTC) in the US real-world setting. This study explores the rapidly evolving and growing treatment landscape in the 2 L setting for advanced or metastatic BTC with a large cohort of patients treated in a community oncology setting.

Methods

Adult patients with BTC initiating 2 L treatment after a platinum-containing first-line between 1/1/10- and 6/30/19 were identified from the US Oncology Network electronic healthcare record database and followed through 12/31/19. Baseline patient and treatment characteristics were analyzed descriptively, including overall response rate (ORR) in the real-world clinical setting. Kaplan-Meier methods were used to measur

SUBMITTER: Cosgrove DP 

PROVIDER: S-EPMC9972013 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature